Ground Breakers: Over $7 billion will be spent by Aussie lithium miners as prices hit export dollars
Lithium is rivalling iron ore for the money producers will spend to increase production despite prices falling off a cliff Canberra forecasters continue to see [more…]
Arizona Lithium strengthens balance sheet after raising $16.5m, spurring field work at Prairie
Arizona Lithium has raised $16.5m via a strongly supported share placement Funds have been raised at a 30% premium to the closing price on 13 [more…]
Resources Top 4: Sultan pumped for WA nickel drilling with JV partner Rio
Sultan Resources and its JV partner Rio Tinto submit PoW for nickel drilling at Lake Grace, WA Mt Malcolm has spotted more pegmatite action out [more…]
The Lake Johnston lithium neighbourhood just got another contender with pegmatites confirmed at Mt Malcolm’s flagship project
Field observations and historical drill logs have confirmed the presence of pegmatites in RAB drill spoil Mt Malcolm Mines says the regional geological setting strongly [more…]
Final pieces coming together for Kingsland’s maiden resource at the Leliyn graphite project
Kingsland Minerals rounds out the initial drilling program at Leliyn with all assays now received These final results will be added to upcoming resource estimate [more…]
Navigating ESG, easy as 1-2-3: How to live and prosper in the resources industry
ESG factors are becoming increasingly dominant in investment decisions A variety of Aussie funds use one or more ESG strategies in their investment process Vulcan [more…]
Blue Star nabs approval to drill four more US helium wells
Blue Star Helium secures approval to drill four more wells at its Voyager helium project Approval brings well drilling inventory at the Colorado-based project to [more…]
ASX health stocks: Neuren soars 30% in early Christmas present after Phase 2 trial success
Neuren reports Phase 2 trial shows significant improvements in Phelan-McDermid syndrome Improvements consistently seen across clinically important aspects of Phelan-McDermid syndrome For 10 out of [more…]
ASX health stocks: Neuren soars 30% in early Christmas present after Phase 2 trial success
Neuren reports Phase 2 trial shows significant improvements in Phelan-McDermid syndrome Improvements consistently seen across clinically important aspects of Phelan-McDermid syndrome For 10 out of [more…]
Sophisticated investor group backs Pilot Energy for second time with $3.5M investment
Special Report: A syndicate of sophisticated investors is again injecting a significant sum of cash into Pilot Energy that will allow the company to get [more…]
